| Strides Pharma Science Ltd Industry: (Pharmaceuticals - Indian - Bulk Drugs & Formln) |
|---|
|
BSE Code:
532531
ISIN Demat:
INE939A01011
Book Value(₹): 344.58 NSE Symbol:
STAR
Div & Yield(%):
0.35
Market Cap(₹ Cr): 10,636.70 P/E(TTM):
57.99
EPS(TTM):
19.90
Face Value(₹): 10.00 |
| Dec 25 (₹ Cr) | Dec 24 (₹ Cr) | Dec 23 (₹ Cr) | Dec 22 (₹ Cr) | Dec 21 (₹ Cr) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,139.42 | 1,866.12 | 1,854.50 | 1,979.00 | 1,857.57 |
| Other Income | 2,873.24 | 127.54 | 84.07 | 123.49 | 117.09 |
| Stock Adjustments | 27.20 | -14.87 | -21.04 | -114.26 | 117.53 |
| Total Income | 5,039.86 | 1,978.79 | 1,917.53 | 1,988.23 | 2,092.19 |
| EXPENDITURE : | |||||
| Raw Materials | 1,110.74 | 954.29 | 1,044.57 | 987.26 | 1,106.41 |
| Power and Fuel Cost | 36.00 | 47.90 | 45.54 | 43.76 | 45.82 |
| Other Manufacturing Expenses | 132.85 | 143.04 | 130.03 | 151.87 | 134.86 |
| Selling and Administration Expenses | 246.18 | 192.14 | 182.64 | 260.83 | 171.51 |
| Miscellaneous Expenses | 0.85 | 19.83 | 80.19 | 72.31 | 84.56 |
| Employee Benefit Expenses | 377.59 | 348.92 | 267.01 | 272.09 | 272.72 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 3,135.66 | 272.68 | 167.54 | 200.11 | 276.32 |
| Interest | 145.91 | 139.38 | 138.68 | 74.24 | 65.34 |
| Gross Profit | 2,989.75 | 133.30 | 28.86 | 125.87 | 210.98 |
| Depreciation | 84.61 | 87.41 | 93.62 | 104.37 | 99.34 |
| Profit Before Tax | 2,905.14 | 45.89 | -64.76 | 21.50 | 111.64 |
| Current Tax | -1.46 | -0.12 | -49.84 | -169.66 | 33.65 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 20.39 | 1.46 | -19.60 | 10.98 | -0.26 |
| Reported Net Profit | 2,886.21 | 44.55 | 4.68 | 180.19 | 78.24 |
| Extraordinary Items | -0.12 | -5.53 | -16.32 | 4.23 | 3.26 |
| Adjusted Net Profit | 2,886.33 | 50.08 | 21.00 | 175.96 | 74.98 |
| Adjustment below Net Profit | -2,827.06 | -57.19 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 719.38 | 745.57 | 740.89 | 583.13 | 522.80 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 22.99 | 13.55 | 0.00 | 22.43 | 17.91 |
| P & L Balance carried down | 755.55 | 719.38 | 745.57 | 740.89 | 583.13 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 40.00 | 25.00 | 15.00 | 0.00 | 25.00 |
| Dividend Per Share(Rs) | 4.00 | 2.50 | 1.50 | 0.00 | 2.50 |
| Earnings Per Share-Unit Curr | 313.16 | 4.85 | 0.52 | 20.07 | 8.72 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 346.42 | 383.84 | 380.71 | 379.36 | 362.18 |
| Book Value(Adj)-Unit Curr | 346.42 | 168.20 | 166.83 | 166.24 | 158.71 |
